Dabur has filed a lawsuit against Patanjali Ayurved in the Delhi High Court Tuesday (24th Dec),, alleging that Patanjali aired misleading advertisements claiming its Chyawanprash is the “original” product. Dabur seeks to restrain these ads, arguing they harm its business and mislead consumers. The case is scheduled for a hearing in January.
Today(27th August), The Supreme Court of India has stayed the Central government’s notification omitting Rule 170 of the Drugs and Cosmetics Rules, 1945, which prevents misleading advertisements for Ayurvedic, Siddha, and Unani drugs. Justices Hima Kohli and Sandeep Mehta criticized the Ministry of Ayush for removing the rule despite a prior court order to maintain it.
